Status | Study |
Recruiting |
Study Name: Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma Condition: Renal Cancer Date: 2012-04-18 Interventions: Drug: 124IcG250 Pts will undergo baseline disease assessment with CT scans (chest, abd & pelvis), 12 |
Active, not recruiting |
Study Name: Feasibility Study: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients Condition: Ovarian Cancer Primary Peritoneal Carcinoma Fallopian Tube Date: 2012-01-03 Interventions: Drug: Propranolol 20 mg by mou |
Completed |
Study Name: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer Condition: Ovarian Clear Cell Cystadenocarcinoma Stage III Ovarian Cancer Date: 2010-09-04 Interventions: Drug: Carboplatin Given IV |
Active, not recruiting |
Study Name: Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer Condition: Endometrial Cancer Date: 2010-06-24 Interventions: Genetic: RNA analysis Genetic: reverse tra |
Completed |
Study Name: Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer Condition: Endometrial Cancer Date: 2010-04-07 Interventions: Drug: carboplatin Drug: liposome-encapsula |
Completed |
Study Name: Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Cell Carcinoma Date: 2009-10-29 Interventions: Radiation: intensity-modulated radiation therapy |
Completed |
Study Name: Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney Condition: Kidney Cancer Date: 2009-02-26 Interventions: Biological: aldesleukin SQ Ald |
Completed |
Study Name: Ovarian Clear Cell Adenocarcinoma Review Condition: [M]Ovarian Cystadenoma or Carcinoma Date: 2009-01-04 |
Completed |
Study Name: Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer Condition: Endometrial Cancer Date: 2008-10-08 Interventions: Drug: ridaforolimus oral ridaf |
Completed |
Study Name: Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer Condition: Carcinoma Adenocarcinoma Renal Cell Date: 2008-07-15 Interventions: Drug: RAD001(everolimus) 10 mg |